|
⚲
|
| Keyboard |
| Mark Iwicki | |
|---|---|
| Firm | |
| Address | 1167 Massachusetts Avenue Arlington, MA 02476 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Kala Bio Inc | 021-533926 | Executive Officer | 10.7 M of 10.7 M |
||
| Kala Bio Inc | 021-517395 | Executive Officer | 12.5 M of 12.5 M |
||
| Kala Pharmaceuticals Inc | 021-422740 | Executive Officer | 16.1 M of 36.5 M |
||
| Pulmatrix Inc | 021-407016 | Director | 0.0 M of 19.6 M |
||
| Pulmatrix Inc | 021-390232 | Director | of 3.2 M |
||
| Pulmatrix Inc | 021-371403 | Director | of 19.6 M |
||
| Pulmatrix Inc | 021-365719 | Director | 8.1 M of 8.1 M |
||
| Pulmatrix Inc | 021-332822 | Director | 2.5 M of 2.5 M |
||
| Pulmatrix Inc | 021-332820 | Director | 0.0 M of 0.0 M |
||
| Pulmatrix Inc | 021-332821 | Director | 0.1 M of 0.1 M |
||
| Merus NV | 021-329437 | Director | 15.0 M of 15.0 M |
||
| Akero Therapeutics Inc | 021-328356 | Director | 45.5 M of 45.5 M |
||
| Pulmatrix Inc | 021-328345 | Director | 3.7 M of 3.7 M |
||
| Aimmune Therapeutics Inc | 021-326810 | Director | 98.0 M of 98.0 M |
||
| Aimmune Therapeutics Inc | 021-307907 | Director | 156.7 M of 156.7 M |
||
| Merus NV | 021-306676 | Director | 55.8 M of 55.8 M |
||
| Merus NV | 021-279136 | Director | 80.0 M of 80.0 M |
||
| Kala Pharmaceuticals Inc | 021-261236 | Executive Officer | 67.9 M of 67.9 M |
||
| Kala Pharmaceuticals Inc | 021-246095 | Executive Officer | 7.0 M of 7.0 M |
||
| Civitas Therapeutics Inc | 021-223855 | Executive Officer | 55.2 M of 55.2 M |
||
| Blend Therapeutics Inc | 021-188774 | Executive Officer | 21.0 M of 21.0 M |
||